Przejdź do zawartości
Merck

Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.

Bioorganic & medicinal chemistry letters (2009-08-18)
Pengcheng P Shao, Feng Ye, Ann E Weber, Xiaohua Li, Kathryn A Lyons, William H Parsons, Maria L Garcia, Birgit T Priest, McHardy M Smith, John P Felix, Brande S Williams, Gregory J Kaczorowski, Erin McGowan, Catherine Abbadie, William J Martin, Daniel R McMasters, Ying-Duo Gao
ABSTRAKT

A series of novel isoxazole voltage gated sodium channel blockers have been synthesized and evaluated. Substitutions on the benzylic position of benzamide were investigated to determine their effect on Na(v)1.7 inhibitory potency. The spirocyclobutyl substitution had the most significant enhancement on Na(v)1.7 inhibitory activity.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
1-Cyclopentenecarboxylic acid, 98%
SKU
Gabaryty przesyłki
Dostępność
Cena netto
Ilość